Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04357873
Title Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations (PEVOsq)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications

anal canal squamous cell carcinoma

vulva squamous cell carcinoma

lung squamous cell carcinoma

penis squamous cell carcinoma

cervical squamous cell carcinoma

head and neck squamous cell carcinoma

Therapies

Pembrolizumab + Vorinostat

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.